- Agrochemical maker Bayer will pay up to $7. 25 billion over two decades to resolve thousands of claims from U.S. cancer patients asserting the company should have warned people that its popular weedkiller Roundup could cause lymphoma, according to a settlement approved Friday by a Missouri judge.

The nationwide settlement applies both to Roundup users who already are ill and those who become diagnosed with non-Hodgkin lymphoma in future years.

Participants could get an average of between $10,000 and $165,000, depending on how they used the product, how old they were when diagnosed and the severity of their illness.